Sign in
8-K

Current Report

Denali Therapeutics Inc. Filed Acc 0001628280-22-004300

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading dnli-20220228.htm…